the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

* View All Categories
View Conferences
Japanese Korean Chinese

Annual Information Service

The Outlook for Pharmaceuticals in Western Europe to 2013

Published by Espicom Business Intelligence Contact us : +1-860-674-8796
Published Issues / Year: 4 Content info  
Product code ES70759
Price From  US $ 3790 Order/Price list
US $ 3790 Hard Copy
US $ 3790 PDF by E-mail (Single User License)
US $ 3790 Web Access (Single User License)
Delivery Time
PDF by E-Mail
Approx. 1-2 business days
Hard Copy/CD-ROM
Approx. 3-4 business days
If you need expedited delivery, please call us.
Description

Abstract

The countries of Western Europe represent a total market of over 403 million people and a combined GDP of US$18.1 trillion in 2008. Each country report in this regional collection provides a comprehensive analysis of the pharmaceutical market, including five-year market forecasts. For each country you will receive 4 completely updated reports sent quarterly, plus comprehensive report sent annually.

The countries of Western Europe represent a total market of over 403 million people and a combined GDP of US$18.1 trillion in 2007.

The 11 main Western European markets for pharmaceuticals are wealthy and mature. Is there any point in manufacturers trying to break into markets they are not already servicing, and, if yes, where? If they are already operating in the region, what are the prospects for growth and what operating environment will they face in the future?

Valuable markets...

News stories chronicle the pressures and problems facing governments trying to expand or maintain health provision in a costconstrained world. But one fact remains. The countries covered by this report represented a total pharmaceutical market value of US$239.1 billion in 2008. We forecast this figure will grow by US$78.6 billion over the next five years to US$317.7 billion!

...with cost pressures

All health funders are experiencing difficulties in meeting the demands on modern health systems. Pressures arise from many quarters including:

  • The cost of current branded medicines which is leading to accelerated growth in generic usage in key markets such as Spain and France
  • The often high cost of new therapies which provide marginal therapeutic benefit
  • An ageing population needing longer and more intensive medical treatments
  • Unplanned population increase due to immigration and an influx of migrant workers

These reports analyse the issues

The Outlook for Pharmaceutical Markets in Western Europe to 2013 is a unique collection of management reports from Espicom Business Intelligence. Each report provides individual and highly-detailed analysis of each market, looking at the key regulatory, political, economic and corporate developments in the wider context of market structure, service and access. The reports are available individually, or as a discounted collection, and prices include 4 completely updated reports sent quarterly, plus comprehensive report sent annually. There are over 60 markets covered in the worldwide series.

11 Key Markets Covered!

  • Austria
  • Belgium
  • France
  • Germany
  • Ireland
  • Italy
  • Netherlands
  • Portugal
  • Spain
  • Switzerland
  • United Kingdom

FOR EVERY MARKET, SENT QUARTERLY

MARKET OUTLOOK

  • Current market size
  • Unique 5-Year market projections to 2013
  • Market outlook
  • Comment & rating, covering 8 key areas such as use of generic drugs, intellectual property, pricing and the health systems
  • Market structure
  • Statistical data on imports and exports
  • Market developments, covering recent and impending developments with respect to key issues such as regulation, health facilities, funding and government policy
  • Key national data projections

FOR EVERY MARKET, SENT ANNUALLY

BACKGROUND DATA

  • Population data, including growth trends and age structure
  • Demographic indicators detailing principal causes of death and morbidity

HEALTHCARE SYSTEM

  • Organisation & administration
  • Health expenditure
    • - Expenditure by source of funding and type
  • Hospital services
    • - Hospital data such as beds by type, region, specialty, patient admissions and surgical procedures
  • Outpatient care
  • Medical personnel
    • - Data on healthcare professionals covering such areas as doctors by specialty, nursing staff and dentists

ACCESSING THE PHARMA MARKET

  • Regulatory environment
  • Distribution guide and trade fair information
  • Domestic production
  • Producers
Related Report
Back to Top
Please inform me when related publications are released
InfoWatch

US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.